Brief: BB Biotech Q3 Net Loss At CHF 208 Mln

Bb Biotech AG

22/10/2021 06:10

Oct 22 (Reuters) - BB BIOTECH AG  BION.S :
    * Q3 INVESTMENT LEVEL DECREASED SLIGHTLY FROM 107.5% TO
106.8% 
    * GAINS REALIZED FOLLOWING COVID-19 VACCINE BOOSTER UPDATE
ENABLE
INCREASES IN ONCOLOGY AND CNS
    * Q3 NET LOSS WAS CHF 208 MN COMPARED TO A NET LOSS OF CHF
395 MN
FOR SAME PERIOD IN 2020

Further company coverage:  BION.S 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))